Refractory Angina Cell Therapy (ReACT) Involving Autologous Bone Marrow Cells in Patients without Left Ventricular Dysfunction: A Possible Role for Monocytes
Autologous bone marrow mononuclear cell (BMMC) transplantation has emerged as a potential therapeutic option for refractory angina patients. Previous studies have shown conflicting myocardium reperfusion results. The present study evaluated safety and efficacy of CellPraxis Refractory Angina Cell Th...
Main Authors: | Nelson Americo Hossne, Adriana Luckow Invitti, Enio Buffolo, Silvia Azevedo, Jose Salvador Rodrigues de Oliveira, Noedir Groppo Stolf, L. Eduardo Cruz, Paul R. Sanberg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-12-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368909X484671 |
Similar Items
-
Long-Term and Sustained Therapeutic Results of a Specific Promonocyte Cell Formulation in Refractory Angina: ReACT (Refractory Angina Cell Therapy) Clinical Update and Cost-Effective Analysis
by: Americo Hossne Nelson, et al.
Published: (2015-06-01) -
Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
by: Ercilla Jose, et al.
Published: (2011-10-01) -
Terapia celular associada à revascularização transmiocárdica laser como proposta no tratamento da angina refratária Cell therapy plus transmyocardial laser revascularization: a proposed alternative procedure for refractory angina
by: Luís Alberto Oliveira Dallan, et al.
Published: (2008-03-01) -
Editorial: The impact of endometriosis
by: Adriana Luckow Invitti, et al.
Published: (2023-05-01) -
Autologous CD34 Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study
by: Timothy D. Henry, et al.
Published: (2016-09-01)